Free Trial

Arrowhead Pharmaceuticals (ARWR) Competitors

Arrowhead Pharmaceuticals logo
$20.51 +1.73 (+9.21%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$20.58 +0.06 (+0.32%)
As of 08/15/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARWR vs. BBIO, VRNA, ELAN, BPMC, ROIV, GRFS, LEGN, RVMD, RYTM, and RNA

Should you be buying Arrowhead Pharmaceuticals stock or one of its competitors? The main competitors of Arrowhead Pharmaceuticals include BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), Elanco Animal Health (ELAN), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), Grifols (GRFS), Legend Biotech (LEGN), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

Arrowhead Pharmaceuticals vs. Its Competitors

BridgeBio Pharma (NASDAQ:BBIO) and Arrowhead Pharmaceuticals (NASDAQ:ARWR) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

In the previous week, Arrowhead Pharmaceuticals had 17 more articles in the media than BridgeBio Pharma. MarketBeat recorded 36 mentions for Arrowhead Pharmaceuticals and 19 mentions for BridgeBio Pharma. BridgeBio Pharma's average media sentiment score of 0.68 beat Arrowhead Pharmaceuticals' score of 0.66 indicating that BridgeBio Pharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BridgeBio Pharma
9 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Arrowhead Pharmaceuticals
12 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

BridgeBio Pharma has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Arrowhead Pharmaceuticals has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500.

99.9% of BridgeBio Pharma shares are held by institutional investors. Comparatively, 62.6% of Arrowhead Pharmaceuticals shares are held by institutional investors. 18.2% of BridgeBio Pharma shares are held by company insiders. Comparatively, 4.3% of Arrowhead Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

BridgeBio Pharma currently has a consensus target price of $61.35, indicating a potential upside of 19.55%. Arrowhead Pharmaceuticals has a consensus target price of $43.14, indicating a potential upside of 110.35%. Given Arrowhead Pharmaceuticals' higher possible upside, analysts plainly believe Arrowhead Pharmaceuticals is more favorable than BridgeBio Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BridgeBio Pharma
0 Sell rating(s)
0 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
3.00
Arrowhead Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.00

BridgeBio Pharma has higher revenue and earnings than Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals is trading at a lower price-to-earnings ratio than BridgeBio Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgeBio Pharma$221.90M44.21-$535.76M-$4.09-12.55
Arrowhead Pharmaceuticals$3.55M798.79-$599.49M-$1.28-16.02

Arrowhead Pharmaceuticals has a net margin of 0.00% compared to BridgeBio Pharma's net margin of -329.25%. BridgeBio Pharma's return on equity of 0.00% beat Arrowhead Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
BridgeBio Pharma-329.25% N/A -85.69%
Arrowhead Pharmaceuticals N/A -40.91%-11.62%

Summary

BridgeBio Pharma beats Arrowhead Pharmaceuticals on 9 of the 16 factors compared between the two stocks.

Get Arrowhead Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARWR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARWR vs. The Competition

MetricArrowhead PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.84B$3.14B$5.73B$9.79B
Dividend YieldN/A2.21%3.90%4.13%
P/E Ratio-16.0220.7631.0725.05
Price / Sales798.79369.14444.16106.06
Price / CashN/A41.5625.2228.44
Price / Book13.329.649.255.96
Net Income-$599.49M-$54.74M$3.26B$265.21M
7 Day Performance24.91%6.56%7.39%4.22%
1 Month Performance8.81%4.82%4.22%0.77%
1 Year Performance-9.65%15.81%30.30%24.69%

Arrowhead Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARWR
Arrowhead Pharmaceuticals
4.1945 of 5 stars
$20.51
+9.2%
$43.14
+110.4%
-9.6%$2.84B$3.55M-16.02400Trending News
Insider Trade
Analyst Revision
Gap Up
High Trading Volume
BBIO
BridgeBio Pharma
4.359 of 5 stars
$48.24
+3.6%
$61.35
+27.2%
+110.3%$9.22B$221.90M-11.79400Insider Trade
VRNA
Verona Pharma PLC American Depositary Share
2.3705 of 5 stars
$105.24
0.0%
$109.00
+3.6%
+282.9%$8.96B$42.28M-106.3030Positive News
Short Interest ↓
ELAN
Elanco Animal Health
2.9071 of 5 stars
$17.10
+2.6%
$17.33
+1.3%
+24.1%$8.50B$4.44B19.899,000News Coverage
BPMC
Blueprint Medicines
N/A$129.46
flat
$130.00
+0.4%
N/A$8.36B$562.12M-52.41640
ROIV
Roivant Sciences
2.9883 of 5 stars
$11.17
-2.8%
$16.50
+47.7%
+5.9%$7.59B$29.05M-44.68860News Coverage
Gap Down
GRFS
Grifols
3.6884 of 5 stars
$10.60
-0.6%
$10.30
-2.8%
+51.8%$7.29B$7.81B9.0623,822Positive News
Ex-Dividend
Short Interest ↑
LEGN
Legend Biotech
3.7348 of 5 stars
$36.24
-2.1%
$73.33
+102.4%
-34.1%$6.66B$728.30M-61.422,609News Coverage
Earnings Report
Analyst Forecast
RVMD
Revolution Medicines
4.164 of 5 stars
$34.70
-0.9%
$68.82
+98.3%
-15.2%$6.49B$11.58M-7.71250News Coverage
Analyst Forecast
Gap Up
RYTM
Rhythm Pharmaceuticals
3.7419 of 5 stars
$94.31
+2.5%
$101.57
+7.7%
+111.8%$6.26B$130.13M-31.33140News Coverage
Insider Trade
RNA
Avidity Biosciences
3.1828 of 5 stars
$45.75
-1.2%
$67.00
+46.4%
+3.3%$5.51B$8.93M-15.25190Positive News
Insider Trade

Related Companies and Tools


This page (NASDAQ:ARWR) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners